Skip to content

Net margin at other companies

Amgen logo
AmgenAMGN
21%+3.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-832.6%+132pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-4,987.4%-8,966pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-49.9%-22.6pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-7,965.8%-10,750pp

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Calculated from Upstream Bio, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s net margin?
Upstream Bio, Inc. (UPB) reported net margin of -4,719% in Q1 2026.
How has Upstream Bio, Inc.'s net margin changed year-over-year?
Upstream Bio, Inc.'s net margin decreased by 36.8% year-over-year, from -3,448.7% to -4,719%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.